Take 5 minutes to catch up on NeurologyLive's highlights from the week ending September 11, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
This episode of Mind Moments features Stewart Tepper, MD, and as part of a NeurologyLive multimedia series, explores the transformation of migraine care in the last 30 years, particularly in the development of targeted therapeutics for the disease.
The neurology resident at NYU Langone described psychosocial implications that physicians faced during the COVID-19 pandemic and the toll it takes on them.
James Beck, PhD, chief scientific officer at the Parkinson’s Foundation shares his perspective on the current state of Parkinson research and development amid the challenges of the pandemic.
Michael R. Sperling, MD, and Amit Verma, MD, review challenging epilepsy cases and their treatment.
Researchers noted that the findings are encouraging for the use of real-world data and natural history data to augment, or possibly replace, placebo controls in DMD trials.